MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/s2665-9913(22)00260-0

Медицинская библиотека · The Lancet. Rheumatology · 2022

Pan American League of Associations for Rheumatology guidelines for the treatment of giant cell arteritis.

Scolnik Marina, Brance Maria L, Fernández-Ávila Daniel G, Inoue Sato Emilia, de Souza Alexandre W S, Magri Sebastián J, Saldarriaga-Rivera Lina M, Ugarte-Gil Manuel F, Flores-Suarez Luis F, Babini Alejandra, Zamora Natalia V, Acosta Felquer María L, Vergara Facundo, Carlevaris Leandro, Scarafia Santiago, Soriano Guppy Enrique R, Unizony Sebastian, Pan American League of Associations for Rheumatology (PANLAR)

СтатьяОбзорПеревод в очереди

Аннотация

Considerable variability exists in the way that health-care providers treat patients with giant cell arteritis in Latin America, with patients commonly exposed to excessive amounts of glucocorticoids. In addition, large health disparities prevail in this region due to socioeconomic factors, which influence access to care, including biological treatments. For these reasons, the Pan American League of Associations for Rheumatology developed the first evidence-based giant cell arteritis treatment guidelines tailored for Latin America. A panel of vasculitis experts from Mexico, Colombia, Peru, Brazil, and Argentina generated clinically meaningful questions related to the treatment of giant cell arteritis in the population, intervention, comparator, and outcome (PICO) format. Following the grading of recommendations, assessment, development, and evaluation methodology, a team of methodologists did a systematic literature search, extracted and summarised the effects of the interventions, and graded the quality of the evidence. The panel of vasculitis experts voted on each PICO question and made recommendations, which required at least 70% agreement among the voting members to be included in the guidelines. Nine recommendations and one expert opinion statement for the treatment of giant cell arteritis were developed considering the most up-to-date evidence and the socioeconomic characteristics of Latin America. These recommendations include guidance for the use of glucocorticoids, tocilizumab, methotrexate, and aspirin for patients with giant cell arteritis.

Для цитирования: Scolnik Marina, Brance Maria L, Fernández-Ávila Daniel G, Inoue Sato Emilia, de Souza Alexandre W S, Magri Sebastián J, Saldarriaga-Rivera Lina M, Ugarte-Gil Manuel F, Flores-Suarez Luis F, Babini Alejandra, Zamora Natalia V, Acosta Felquer María L, Vergara Facundo, Carlevaris Leandro, Scarafia Santiago, Soriano Guppy Enrique R, Unizony Sebastian, Pan American League of Associations for Rheumatology (PANLAR). Pan American League of Associations for Rheumatology guidelines for the treatment of giant cell arteritis.. The Lancet. Rheumatology. 2022. DOI: 10.1016/s2665-9913(22)00260-0.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.